Search research articles
Contact Us
Filters
Showing results (171-180 of 259) with videos related to
Page
of 26
Sort By:
Journal of the American College of Cardiology
|
July 4, 2006
The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study
Benjamin M Scirica, Marc S Sabatine, David A Morrow, et al.
Circulation
|
March 1, 1996
TIMI frame count: a quantitative method of assessing coronary artery flow
C M Gibson, C P Cannon, W L Daley, et al.
Journal of the American College of Cardiology
|
August 15, 2009
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis
Michelle O'Donoghue, Elliott M Antman, Eugene Braunwald, et al.
Journal of the American College of Cardiology
|
July 11, 2002
The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies
James A de Lemos, David A Morrow, C Michael Gibson, et al.
Journal of the American College of Cardiology
|
April 23, 2003
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18
David A Morrow, James A de Lemos, Marc S Sabatine, et al.
Circulation
|
June 22, 2005
Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial
Stephen D Wiviott, Elliott M Antman, Kenneth J Winters, et al.
Journal of the American College of Cardiology
|
October 18, 2005
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial
Kausik K Ray, Christopher P Cannon, Richard Cairns, et al.
Journal of the American College of Cardiology
|
April 1, 1994
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial
C P Cannon, C H McCabe, T D Henry, et al.
Circulation
|
March 17, 2005
Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment
Marc S Sabatine, Gavin J Blake, Mark H Drazner, et al.
Irish Journal of Medical Science
|
January 8, 2018
Aciclovir-induced acute kidney injury in patients with 'suspected viral encephalitis' encountered on a liaison neurology service
Petya Bogdanova-Mihaylova, David Burke, John P O'Dwyer, et al.
Page
of 26
Search research articles
Search
Showing results (171-180 of 259) with videos related to
Sort By:
Page
of 26
Journal of the American College of Cardiology
|
July 4, 2006
The role of clopidogrel in early and sustained arterial patency after fibrinolysis for ST-segment elevation myocardial infarction: the ECG CLARITY-TIMI 28 Study
Benjamin M Scirica, Marc S Sabatine, David A Morrow, et al.
Circulation
|
March 1, 1996
TIMI frame count: a quantitative method of assessing coronary artery flow
C M Gibson, C P Cannon, W L Daley, et al.
Journal of the American College of Cardiology
|
August 15, 2009
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel-Thrombolysis In Myocardial Infarction 38) analysis
Michelle O'Donoghue, Elliott M Antman, Eugene Braunwald, et al.
Journal of the American College of Cardiology
|
July 11, 2002
The prognostic value of serum myoglobin in patients with non-ST-segment elevation acute coronary syndromes. Results from the TIMI 11B and TACTICS-TIMI 18 studies
James A de Lemos, David A Morrow, C Michael Gibson, et al.
Journal of the American College of Cardiology
|
April 23, 2003
Evaluation of B-type natriuretic peptide for risk assessment in unstable angina/non-ST-elevation myocardial infarction: B-type natriuretic peptide and prognosis in TACTICS-TIMI 18
David A Morrow, James A de Lemos, Marc S Sabatine, et al.
Circulation
|
June 22, 2005
Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial
Stephen D Wiviott, Elliott M Antman, Kenneth J Winters, et al.
Journal of the American College of Cardiology
|
October 18, 2005
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial
Kausik K Ray, Christopher P Cannon, Richard Cairns, et al.
Journal of the American College of Cardiology
|
April 1, 1994
A pilot trial of recombinant desulfatohirudin compared with heparin in conjunction with tissue-type plasminogen activator and aspirin for acute myocardial infarction: results of the Thrombolysis in Myocardial Infarction (TIMI) 5 trial
C P Cannon, C H McCabe, T D Henry, et al.
Circulation
|
March 17, 2005
Influence of race on death and ischemic complications in patients with non-ST-elevation acute coronary syndromes despite modern, protocol-guided treatment
Marc S Sabatine, Gavin J Blake, Mark H Drazner, et al.
Irish Journal of Medical Science
|
January 8, 2018
Aciclovir-induced acute kidney injury in patients with 'suspected viral encephalitis' encountered on a liaison neurology service
Petya Bogdanova-Mihaylova, David Burke, John P O'Dwyer, et al.
Page
of 26